Dr Emilie Sitterlé is a PharmD., specialized in Medical Biology. She has different areas of expertise in the field of Medical Microbiology specially in Mycology. She is currently a PhD student in the Fungal Biology and Pathogenicity Unit. She works on the genomic diversity of Candida albicans, especially focusing on genetic and phenotypic changes that occur during commensal and pathological carriage.
Click to view graph
Connections
Click to view timeline
Timeline
Former Teams
Publications
Download-
2019Within-Host Genomic Diversity of Candida albicans in Healthy Carriers, Sci Rep 2019 Feb;9(1):2563.
-
2015Prospective evaluation of azole resistance in Aspergillus fumigatus clinical isolates in France, Med. Mycol. 2015 Aug;53(6):593-6.
-
2015Contribution of (1,3)-beta-D-glucan to diagnosis of invasive candidiasis after liver transplantation, J. Clin. Microbiol. 2015 Mar;53(3):771-6.
-
2015In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp, J. Med. Microbiol. 2015 Mar;64(Pt 3):309-11.
-
2014Human-impacted areas of France are environmental reservoirs of the Pseudallescheria boydii/Scedosporium apiospermum species complex, Environ. Microbiol. 2015 Apr;17(4):1039-48.
-
2014Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and accurate identification of Pseudallescheria/Scedosporium species, Clin. Microbiol. Infect. 2014 Sep;20(9):929-35.
-
2012Azole preexposure affects the Aspergillus fumigatus population in patients, Antimicrob. Agents Chemother. 2012 Sep;56(9):4948-50.
-
2011Trichophyton bullosum: a new zoonotic dermatophyte species, Med. Mycol. 2012 Apr;50(3):305-9.
-
2010Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies, J. Antimicrob. Chemother. 2011 Feb;66(2):371-4.